- Home
- MGRM vs CLYM Comparison
MGRM vs CLYM Comparison
Compare MGRM & CLYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRM
- CLYM
- Stock Information
- Founded
- MGRM 2016
- CLYM 2018
- Country
- MGRM United States
- CLYM United States
- Employees
- MGRM N/A
- CLYM N/A
- Industry
- MGRM Medical/Dental Instruments
- CLYM
- Sector
- MGRM Health Care
- CLYM
- Exchange
- MGRM Nasdaq
- CLYM NYSE
- Market Cap
- MGRM 79.9M
- CLYM 85.8M
- IPO Year
- MGRM N/A
- CLYM 2021
- Fundamental
- Price
- MGRM $2.41
- CLYM $1.18
- Analyst Decision
- MGRM Strong Buy
- CLYM
- Analyst Count
- MGRM 1
- CLYM 0
- Target Price
- MGRM $5.40
- CLYM N/A
- AVG Volume (30 Days)
- MGRM 69.5K
- CLYM 145.4K
- Earning Date
- MGRM 05-14-2025
- CLYM 05-14-2025
- Dividend Yield
- MGRM N/A
- CLYM N/A
- EPS Growth
- MGRM N/A
- CLYM N/A
- EPS
- MGRM N/A
- CLYM N/A
- Revenue
- MGRM N/A
- CLYM N/A
- Revenue This Year
- MGRM N/A
- CLYM N/A
- Revenue Next Year
- MGRM N/A
- CLYM N/A
- P/E Ratio
- MGRM N/A
- CLYM N/A
- Revenue Growth
- MGRM N/A
- CLYM N/A
- 52 Week Low
- MGRM $1.92
- CLYM $1.05
- 52 Week High
- MGRM $4.21
- CLYM $9.58
- Technical
- Relative Strength Index (RSI)
- MGRM 38.50
- CLYM N/A
- Support Level
- MGRM $2.54
- CLYM N/A
- Resistance Level
- MGRM $2.69
- CLYM N/A
- Average True Range (ATR)
- MGRM 0.19
- CLYM 0.00
- MACD
- MGRM -0.02
- CLYM 0.00
- Stochastic Oscillator
- MGRM 13.79
- CLYM 0.00
About MGRM Monogram Orthopaedics Inc.
Monogram Technologies Inc develops a product solution architecture to enable patient-optimized orthopedic implants at scale by linking 3D printing and robotics with advanced pre-operative imaging. The company has a robot prototype that can autonomously execute optimized paths for high-precision insertion of implants in synthetic bone specimens. Monogram also intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation necessary for reconstructive joint replacement procedures.
About CLYM CLIMB BIO INC
Climb Bio Inc is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. its product candidate, budoprutug, is an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has the potential to treat a broad range of B-cell-mediated diseases.